Literature DB >> 21622821

Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension.

Lori A Walker1, John S Walker, Amelia Glazier, Dale R Brown, Kurt R Stenmark, Peter M Buttrick.   

Abstract

Right ventricular (RV) failure is one of the strongest predictors of mortality both in the presence of left ventricular decompensation and in the context of pulmonary vascular disease. Despite this, there is a limited understanding of the biochemical and mechanical characteristics of the pressure-overloaded RV at the level of the cardiac myocyte. To better understand this, we studied ventricular muscle obtained from neonatal calves that were subjected to hypobaric atmospheric conditions, which result in profound pulmonary hypertension. We found that RV pressure overload resulted in significant changes in the phosphorylation of key contractile proteins. Total phosphorylation of troponin I was decreased with pressure overload, predominantly reflecting changes at the putative PKA site at Ser(22/23). Similarly, both troponin T and myosin light chain 2 showed a significant decline in phosphorylation. Desmin was unchanged, and myosin-binding protein C (MyBP-C) phosphorylation was apparently increased. However, the apparent increase in MyBP-C phosphorylation was not due to phosphorylation but rather to an increase in MyBP-C total protein. Importantly, these findings were seen in all regions of the RV and were paralleled by reduced Ca(2+) sensitivity with preserved maximal Ca(2+) saturated developed force normalized to cross-sectional area in isolated skinned right ventricular myocyte fragments. No changes in total force or cooperativity were seen. Taken together, these results suggest that RV failure is mechanistically unique from left ventricular failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622821      PMCID: PMC3191097          DOI: 10.1152/ajpheart.00249.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  53 in total

1.  Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression.

Authors:  T J Herron; F S Korte; K S McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

2.  Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.

Authors:  N W Morrell; S M Danilov; K B Satyan; K G Morris; K R Stenmark
Journal:  Cardiovasc Res       Date:  1997-05       Impact factor: 10.787

3.  Neonatal calves develop airflow limitation due to chronic hypobaric hypoxia.

Authors:  S C Inscore; K R Stenmark; C Orton; C G Irvin
Journal:  J Appl Physiol (1985)       Date:  1991-01

Review 4.  Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Authors:  Kurt R Stenmark; Karen A Fagan; Maria G Frid
Journal:  Circ Res       Date:  2006-09-29       Impact factor: 17.367

5.  Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T.

Authors:  Marius P Sumandea; W Glen Pyle; Tomoyoshi Kobayashi; Pieter P de Tombe; R John Solaro
Journal:  J Biol Chem       Date:  2003-06-28       Impact factor: 5.157

6.  Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.

Authors:  Adam M Jacques; O'Neal Copeland; Andrew E Messer; Clare E Gallon; Katie King; William J McKenna; Victor T Tsang; Steven B Marston
Journal:  J Mol Cell Cardiol       Date:  2008-06-04       Impact factor: 5.000

7.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

8.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

9.  Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution.

Authors:  Xiaoke Yin; Friederike Cuello; Ursula Mayr; Zhiqi Hao; Martin Hornshaw; Elisabeth Ehler; Metin Avkiran; Manuel Mayr
Journal:  Mol Cell Proteomics       Date:  2009-12-27       Impact factor: 5.911

10.  The right ventricle: biologic insights and response to disease.

Authors:  Lori A Walker; Peter M Buttrick
Journal:  Curr Cardiol Rev       Date:  2009-01
View more
  15 in total

1.  Organ-level right ventricular dysfunction with preserved Frank-Starling mechanism in a mouse model of pulmonary arterial hypertension.

Authors:  Zhijie Wang; Jitandrakumar R Patel; David A Schreier; Timothy A Hacker; Richard L Moss; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2018-01-25

2.  Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.

Authors:  Aiping Liu; David Schreier; Lian Tian; Jens C Eickhoff; Zhijie Wang; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-06       Impact factor: 4.733

Review 3.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

Review 4.  Pressure-overload-induced right heart failure.

Authors:  S Rain; M L Handoko; A Vonk Noordegraaf; H J Bogaard; J van der Velden; F S de Man
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

5.  Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.

Authors:  Steven Hsu; Kristen M Kokkonen-Simon; Jonathan A Kirk; Todd M Kolb; Rachel L Damico; Stephen C Mathai; Monica Mukherjee; Ami A Shah; Fredrick M Wigley; Kenneth B Margulies; Paul M Hassoun; Marc K Halushka; Ryan J Tedford; David A Kass
Journal:  Circulation       Date:  2018-01-19       Impact factor: 29.690

6.  Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.

Authors:  Arnica Behringer; Manuela Trappiel; Eva Maria Berghausen; Henrik Ten Freyhaus; Ernst Wellnhofer; Margarete Odenthal; Florian Blaschke; Fikret Er; Natig Gassanov; Stephan Rosenkranz; Stephan Baldus; Kai Kappert; Evren Caglayan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-07       Impact factor: 3.000

7.  Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.

Authors:  Danielle R Bruns; Peter M Buttrick; Lori A Walker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

Review 8.  Cardiac tissue structure, properties, and performance: a materials science perspective.

Authors:  Mark Golob; Richard L Moss; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2014-08-01       Impact factor: 3.934

9.  MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.

Authors:  R Dale Brown; S Kelly Ambler; Min Li; Timothy M Sullivan; Lauren N Henry; Joseph T Crossno; Carlin S Long; Timothy P Garrington; Kurt R Stenmark
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

Review 10.  Pulmonary vascular mechanics: important contributors to the increased right ventricular afterload of pulmonary hypertension.

Authors:  Zhijie Wang; Naomi C Chesler
Journal:  Exp Physiol       Date:  2013-05-10       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.